These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10515799

  • 1. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
    Wideroff L, Schiffman M, Haderer P, Armstrong A, Greer CE, Manos MM, Burk RD, Scott DR, Sherman ME, Schiller JT, Hoover RN, Tarone RE, Kirnbauer R.
    J Infect Dis; 1999 Nov; 180(5):1424-8. PubMed ID: 10515799
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.
    J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
    Xi LF, Touré P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB.
    Int J Cancer; 2003 Mar 01; 103(6):803-9. PubMed ID: 12516102
    [Abstract] [Full Text] [Related]

  • 5. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.
    Marais DJ, Best JM, Rose RC, Keating P, Soeters R, Denny L, Dehaeck CM, Nevin J, Kay P, Passmore JA, Williamson AL.
    J Med Virol; 2001 Sep 01; 65(1):149-54. PubMed ID: 11505457
    [Abstract] [Full Text] [Related]

  • 6. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
    Wideroff L, Schiffman MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lorincz AT, Manos MM, Glass AG, Scott DR, Sherman ME, Buckland J, Lowy D, Schiller J.
    J Infect Dis; 1996 Nov 01; 174(5):937-43. PubMed ID: 8896493
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D, Rose RC, Williamson AL.
    J Med Virol; 1997 Feb 01; 51(2):126-31. PubMed ID: 9021543
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Human papillomavirus genotype distribution in cervical infections among woman in La Plata, Argentina].
    Abba MC, Gomez MA, Golijow CD.
    Rev Argent Microbiol; 2003 Feb 01; 35(2):74-9. PubMed ID: 12920987
    [Abstract] [Full Text] [Related]

  • 11. Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus.
    Wallin KL, van Doornum GJ, Andersson-Ellström A, Kallings I, Wiklund F, Hallmans G, Schiller J, Dillner J.
    Int J Cancer; 2000 Feb 01; 85(3):353-7. PubMed ID: 10652426
    [Abstract] [Full Text] [Related]

  • 12. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions.
    Kim CJ, Jeong JK, Park M, Park TS, Park TC, Namkoong SE, Park JS.
    Gynecol Oncol; 2003 May 01; 89(2):210-7. PubMed ID: 12713982
    [Abstract] [Full Text] [Related]

  • 13. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group.
    J Med Microbiol; 2020 Jul 01; 69(7):960-970. PubMed ID: 32510304
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction.
    Lehtinen M, Luukkaala T, Wallin KL, Paavonen J, Thoresen S, Dillner J, Hakama M.
    J Clin Virol; 2001 Aug 01; 22(1):117-24. PubMed ID: 11418359
    [Abstract] [Full Text] [Related]

  • 15. [Detection of human papillomavirus genome in cervical squamous intraepithelial lesions].
    Dudkiewicz J, Waksmański B, Cieślak-Steć M.
    Ginekol Pol; 2001 Dec 01; 72(12A):1489-96. PubMed ID: 11883302
    [Abstract] [Full Text] [Related]

  • 16. [The role of human papillomavirus in cyto-histological practice: distribution and prevalenceof hig-risk strains (16, 18, 31, 33, and 35) in intraepithelial lesions and neoplasia of the uterine cervix].
    Voglino G, Poso F, Privitera S, Parisio F, Ghiringhello B, Gordini G, Chiara G, Massobrio M, Fessia L.
    Pathologica; 2000 Dec 01; 92(6):516-23. PubMed ID: 11234302
    [Abstract] [Full Text] [Related]

  • 17. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women.
    Lertworapreecha M, Bhattarakosol P, Niruthisard S.
    Southeast Asian J Trop Med Public Health; 1998 Sep 01; 29(3):507-11. PubMed ID: 10437947
    [Abstract] [Full Text] [Related]

  • 18. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A, Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y, Kanda T.
    J Med Virol; 2003 Mar 01; 69(3):441-6. PubMed ID: 12526056
    [Abstract] [Full Text] [Related]

  • 19. Genital papillomavirus in Greek women with high-grade cervical intraepithelial neoplasia and cervical carcinoma.
    Labropoulou V, Diakomanolis E, Dailianas S, Kalpaktsoglou K, Rodolakis A, Beaudenon S, Kakkanas A, Mavromara P.
    J Med Virol; 1996 Jan 01; 48(1):80-7. PubMed ID: 8825715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.